Global landscape and trends in lifetime risks of haematologic malignancies in 185 countries: population-based estimates from GLOBOCAN 2022
Kexin Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Wenqiang Wei(Chinese Academy of Medical Sciences & Peking Union Medical College), Shaoming Wang(Shihezi University), Hongliang Wu(Chinese Academy of Medical Sciences & Peking Union Medical College), Kai Gu(Shanghai Municipal Center For Disease Control Prevention), Hui Wei(Chinese Academy of Medical Sciences & Peking Union Medical College), Bingfeng Han(Chinese Academy of Medical Sciences & Peking Union Medical College), Meicen Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Li Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Ru Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Zheng Rongshou(Chinese Academy of Medical Sciences & Peking Union Medical College), Qian Zhu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yi Pang(Shanghai Municipal Center For Disease Control Prevention), Chunxiao Wu(Shanghai Municipal Center For Disease Control Prevention), Hongmei Zeng(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 24
Related Papers
Cancer incidence and mortality in China, 2022
|Journal of the National Cancer Center|2024|2k
Cancer incidence and mortality in China, 2016
|Journal of the National Cancer Center|2022|1.6k
Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020
|Cancer Communications|2021|1.1k
Cancer registration in China and its role in cancer prevention and control
|The Lancet Oncology|2020|501
Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN
|The Lancet. Gastroenterology & hepatology|2024|248